bezafibrate has been researched along with malondialdehyde in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aviram, M; Brook, GJ; Hoffman, R | 1 |
| Ito, S; Kanno, T; Kobori, K; Kondo, A; Kotani, K; Maekawa, M; Manabe, M; Morita, H; Nakamura, H; Saito, K | 1 |
| Esmat, AY; Gawad, SM; Ibrahim, AM; Mohamed, MA; Refaie, FM | 1 |
| Alam, MM; Anwer, T; Haque, SE; Pillai, KK; Sharma, M; Zaman, MS | 1 |
| Britto, R; da Rosa-Junior, NT; Grings, M; Leipnitz, G; Parmeggiani, B; Wajner, M | 1 |
| Abdelrahman, AM; El-Tahawy, NF; Ibrahim, SA; Mohamed, MZ | 1 |
1 trial(s) available for bezafibrate and malondialdehyde
| Article | Year |
|---|---|
Influence of fibrate treatment on malondialdehyde-modified LDL concentration.
Topics: Adult; Aging; Apolipoproteins B; Arteriosclerosis; Bezafibrate; Diabetes Complications; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Sex Characteristics | 2004 |
5 other study(ies) available for bezafibrate and malondialdehyde
| Article | Year |
|---|---|
Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.
Topics: Adult; Animals; Bezafibrate; Cells, Cultured; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Esterification; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Malondialdehyde; Mice; Middle Aged; Pravastatin; Vitamin E | 1992 |
The antihyperlipidemic activities of 4(3H) quinazolinone and two halogenated derivatives in rats.
Topics: Animals; Bezafibrate; Blood Glucose; Body Weight; Cholesterol, Dietary; Diabetes Mellitus, Experimental; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Malondialdehyde; Quinazolines; Quinazolinones; Rats | 2005 |
Protective effect of bezafibrate on streptozotocin-induced oxidative stress and toxicity in rats.
Topics: Administration, Oral; Animals; Antioxidants; Bezafibrate; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase; Hyperglycemia; Hypolipidemic Agents; Injections, Intraperitoneal; Insulin-Secreting Cells; Islets of Langerhans; Lipid Peroxidation; Liver; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase; Time Factors | 2007 |
Bezafibrate Prevents Glycine-Induced Increase of Antioxidant Enzyme Activities in Rat Striatum.
Topics: Animals; Antioxidants; Bezafibrate; Corpus Striatum; Glutathione; Glycine; Injections, Intraventricular; Malondialdehyde; Rats, Wistar | 2019 |
Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats.
Topics: Actins; Animals; Bezafibrate; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Liver Function Tests; Male; Malondialdehyde; Nitrites; Pioglitazone; Rats; Thioacetamide | 2021 |